About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
BMRN - BioMarin Pharmaceuti...| Previous Close | $119.83 | Open | |
| Volume | 973 | Market Cap | 21.666B |
| Yield | Last Dividend |
| BioMarin Announces Second Quarter 2020 T... | 08/04/20 |
| SAN RAFAEL, Calif., Aug. 4, 2020 /PRNewswire/ -- Financial Highlights (in millions of U.S. dollars, except per share data, unaudited) Three Months End... | |
| Biomarin Pharmaceutical's Earnings: A Pr... | 08/03/20 |
| Biomarin Pharmaceutical (NASDAQ: BMRN) will be releasing its next round of earnings this Tuesday, August 04. For all of the relevant information, here... | |
| The Week Ahead In Biotech: Novavax Coron... | 08/02/20 |
| Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts. COVID-19 news flo... | |
| BioMarin files EU marketing application ... | 07/23/20 |
| BioMarin Pharmaceutical (NASDAQ:BMRN) has submitted a marketing application in Europe seeking approval of vosoritide, a daily injection analog of c-ty... | |
| BioMarin Submits Marketing Authorization... | 07/23/20 |
| /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announced today that the company submitted a Marketing Authorization Application (MAA) to ... | |
| The Daily Biotech Pulse: Aurinia's Kidne... | 07/22/20 |
| Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 21) ABIOMED, Inc. (NASDAQ: ABMD ) Assembly Biosciences Inc (NASDAQ: ASMB ) Bio-Rad Labora... | |
| The Daily Biotech Pulse: Opko Wins CDC C... | 07/21/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 20) Abb... | |
| The Daily Biotech Pulse: Blueprint, Roch... | 07/14/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 13) Alt... | |
| The Daily Biotech Pulse: Intersect ENT J... | 07/08/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7) AbbV... | |
| The Daily Biotech Pulse: Novartis Settle... | 07/02/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 1) AbbV... | |
| BioMarin promotes company veteran to EVP... | 06/29/20 |
| BioMarin Pharmaceutical (NASDAQ:BMRN) promoted 17-year veteran Brian R.Mueller to EVP, CFO from his earlier Senior VP and acting CFO position since Fe... | |
| The Daily Biotech Pulse: Tiziana Snags A... | 06/19/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 18) ADC... | |
| BRIEF-BioMarin Provides New Data from St... | 06/17/20 |
| Biomarin Pharmaceutical Inc: | |
| BioMarin Pharmaceutical : Provides Addit... | 06/17/20 |
| SAN RAFAEL, Calif., June 17, 2020 /PRNewswire/ -- BioMarin Pharmaceutical Inc. announced today additional data from its previously reported four-year ... | |
| The Daily Biotech Pulse: Adamas Rallies ... | 06/05/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 4) Bioh... | |
| The Daily Biotech Pulse: Positive Readou... | 06/04/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peak (Biotech Stocks Hitting 52-week Highs June 3) Arena... | |
| BioMarin Provides Positive Gene Therapy ... | 06/01/20 |
| Global biotech BioMarin Pharmaceutical Inc. (BMRN) has announced updated results of an open-label Phase 1/2 study of valoctocogene roxaparvovec, an in... | |
| BioMarin Pharmaceutical : Provides Highl... | 05/31/20 |
| SAN RAFAEL, Calif., May 31, 2020 /PRNewswire/ -- BioMarin Pharmaceutical Inc. announced today an update to its previously reported results of an open-... | |
| Why Is BioMarin (BMRN) Up 14.8% Since La... | 05/29/20 |
| BioMarin (BMRN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. | |
| The Daily Biotech Pulse: Cumberland's Po... | 05/27/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 26) ADC ... | |
| Jefferies breaks down the top 22 stocks ... | 05/25/20 |
| Jefferies names its 22 top US stock picks, according to the conviction and buy ratings assigned by their analysts. The firm out the investment thesis ... | |
| BioMarin Announces Closing of Exercise b... | 05/19/20 |
| SAN RAFAEL, Calif., May 19, 2020 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that the initial purchasers of the previo... | |
| BioMarin Announces Pricing of Upsized $5... | 05/11/20 |
| SAN RAFAEL, Calif. , May 11, 2020 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) today announced the pricing of $550.0 million aggregate... | |
| BioMarin Announces Proposed Private Offe... | 05/11/20 |
| SAN RAFAEL, Calif., May 11, 2020 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that it intends to offer, subject to mark... | |
| 5 Biopharmas Where BofA Would Put Its Mo... | 05/08/20 |
| Biopharma shares have outperformed the broader market year-to-date, giving rise to apprehension over whether a pullback is in the offing. An analyst a... | |
| BioMarin Strikes Gene Therapy Partnershi... | 05/04/20 |
| BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) is beefing up its gene therapy portfolio. The large-cap biopharma BioMarin said it has entered into a pre... | |
| BioMarin (BMRN) Beats on Q1 Earnings, Lo... | 04/30/20 |
| BioMarin (BMRN) beats estimates for both earnings and sales in the first quarter. It lowers its total revenue outlook for the year due to the potentia... | |
| BioMarin Pharmaceutical (BMRN) Tops Q1 E... | 04/29/20 |
| BioMarin (BMRN) delivered earnings and revenue surprises of 90.91% and 6.73%, respectively, for the quarter ended March 2020. Do the numbers hold clue... | |
| BioMarin Announces First Quarter 2020 To... | 04/29/20 |
| SAN RAFAEL, Calif. , April 29, 2020 /PRNewswire/ -- Financial Highlights (in millions of U.S. dollars, except per share data, unaudited) Three Months ... | |
| Strong Buy rating | 12:00 AM |
| SVB Leerink maintains Outperform rating and raises Price Target from $130.00 to $140.00 | |
| Hold rating | 07/08/20 |
| Morgan Stanley downgrades from Overweight to Equal-Weight rating and announces Price Target of $125.00 | |
| Hold rating | 06/18/20 |
| Oppenheimer maintains Perform rating and raises Price Target from $88.00 to $95.00 | |
| Buy rating | 06/18/20 |
| SunTrust Robinson Humphrey maintains Buy rating and raises Price Target from $109.00 to $143.00 | |
| Buy rating | 06/10/20 |
| B of A Securities maintains Buy rating and raises Price Target from $120.00 to $130.00 | |
| Date | 2020-08-04 (AMC) | Est. (EPS/Rev.) | ($0.11)/ 418.61M |
| Actual (EPS/Rev.) | $-0.16/ $429.49 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Alpha Swing Trades | Jonathan | 68.00 % | Follow |
| Best Trading Ideas | Best Trading Ideas | 53.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
